03.04.2024 • News
Archroma to Expand Operations in South Carolina
Swiss specialty chemicals producer Archroma announced plans to expand its US operations in Martin, South Carolina.
News
02.04.2024 • News
Wolfgang Wienand to Join Lonza as New CEO
Lonza has appointed Wolfgang Wienand as its new CEO. He will join the company during the summer of 2024 and succeed Albert M. Baehny, who took on the additional responsibility of interim CEO in October 2023 while the search for a permanent CEO took place.
02.04.2024 • News
Ineos Completes Acquisition of TotalEnergies’ Petrochemical Assets at Lavera
Ineos has completed the acquisition of Naphtachimie, Gexaro and Appryl, which were 50:50 Joint Ventures between Ineos and TotalEnergies at Lavera in Southern France.
28.03.2024 • News
Aragen Launches First Phase of Biologics Facility in India
Aragen, a CRDMO, has launched the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million project, executed by its subsidiary Aragen Biologics Pvt Ltd, has completed its first small-scale manufacturing project for a US-based organization, producing a novel anticancer monoclonal antibody.
28.03.2024 • News
Syensqo Inaugurates Application Development Labs in Italy
Syensqo has opened its application development labs (ADL) in Bollate, Italy. The project includes an expansion of 1,300 m2 in a new building and represents a €10 million investment over the past three years and underlines the Bollate research center’s pivotal role in developing new applications for high-tech industries, the company said.
27.03.2024 • News
Chemours Names Denise Dignam Permanent CEO
US specialty chemicals and materials company Chemours has appointed Denise Dignam as the company’s permanent CEO and president, as well as a member of the board of directors, effective immediately.
27.03.2024 • News
Celanese and Secarna Collaborate on Long-Acting Antisense Therapies
US chemical group Celanese and Germany’s Secarna Pharmaceuticals, an antisense drug discovery and development company, entered a research collaboration for the development of long-acting implants that deliver antisense oligonucleotides (ASOs).
26.03.2024 • News
Sandoz Opens Antibiotic Production Facility in Austria
Sandoz, a generic and biosimilar medicines manufacturer, recently opened a new production facility in Kundl, Austria, to serve more patients with affordable life-saving drugs produced entirely in Europe.
26.03.2024 • News
Dow to Build World-Scale Carbonate Solvents Facility on US Gulf Coast
Dow announced its intent to build a world-scale carbonate solvents production facility for lithium-ion battery production on the US Gulf Coast. The plant will serve customers in the lithium-ion battery sector, in which carbonate solvents are used as a component in electrolytes.
25.03.2024 • News
Novo Nordisk to Acquire Cardior Pharmaceuticals
Novo Nordisk is to acquire Cardior Pharmaceuticals for up to €1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved.
25.03.2024 • News
Johnson Matthey to Sell its Medical Device Components Business
UK’s Johnson Matthey (JM) has signed a definitive agreement to sell 100% of its Medical Device Components (MDC) business to Montagu Private Equity for $700 million (£550 million).
25.03.2024 • News
Schott Pharma to Build New US Prefillable Syringe Manufacturing Facility
In a move to triple its production of glass and polymer syringes for the US market by 2030, Germany’s Schott Pharma announced plans to build its first US facility to manufacture prefillable polymer syringes that meet the need for deep-cold storage and transportation of mRNA medications.
25.03.2024 • News
AstraZeneca to Buy Fusion Pharmaceuticals for Up to $2.4 Billion
AstraZeneca has agreed to acquire Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
22.03.2024 • News
Afyren Neoxy Gets €3.4 Million in After-Biochem Project
Greentech firm Afyren Neoxy, a subsidiary of Afyren, received a €3.4 million payment this week for achieving key milestones with its bio-based low-carbon products.
21.03.2024 • News
Evonik and Vland Biotech Begin Joint Venture
Evonik Vland Biotech, a new joint venture between Evonik China and Shandong Vland Biotech, began operations on January 1, 2024. The venture aims to expand the market presence of their livestock probiotics in Greater China and develop new products. The official opening took place in Qingdao on March 14.
Securing Supply Chains and Strengthening Partnerships
Interview with Edgardo Hernandez, President Manufacturing, Lilly
20.03.2024 • News
Smart Innovations Replace Fossil-based Products
The CO₂-based Fuels and Chemicals Conference 2024, organized by the Nova Institute, announces six nominees for the innovation award “Best CO₂-Utilisation 2024”. Nominees cover topics from carbon-negative diamonds to CO₂-based fuels for transport.
20.03.2024 • News
Metrohm USA Awards Young Chemist for Research in Combatting Environmental Pollutants
Metrohm USA announced the winner of this year’s $10,000 (€9,200) Young Chemist Award, Ms. Katelyn Michael, a graduate student from the University of Wisconsin-Madison.
Navigating the Logistics Impact
Cell and gene therapies (CGTs) present a revolutionary approach to the pharmaceutical industry. However, several complexities do arise on a logistical spectrum that diverge from those of traditional pharmaceuticals.
Integrated Continuous Manufacturing in Pharmaceuticals
An innovative manufacturing platform called integrated continuous manufacturing (ICM) represents a completely modernized model for drug manufacturing. In contrast to batch processes, ICM’s unique operational advantages will allow for cost-competitive end-to-end manufacturing and enable a more robust and responsive supply chain for critical drugs.
A New Standard of Collaboration for the Pharmaceutical Industry
Headquartered in Cramlington, UK, Sterling Pharma Solutions is a contract development and manufacturing organization (CDMO) that provides a range of services to the global biopharmaceutical industry, including active pharmaceutical ingredient (API) development, scale-up and cGMP manufacturing, as well as antibody drug conjugate (ADC) R&D and clinical-scale GMP manufacturing.
The Future of mRNA Technology
mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its potential. Experts see a wide range of potential applications for this relatively new technology, particularly in infectious diseases and cancer.
Sustainability and Energy Efficiency at a Turning Point
Flow chemistry was named as one of the ten technologies that have the potential to make our planet more sustainable in 2019 by the IUPAC.
Sustainability in Production is Key - What Does Flow Chemistry Bring to the Table?
Numerous articles have been published within the last years in chemical science and business media (including this one) on the advantages of continuous reactions, aka flow chemistry.
AI-Powered Knowledge Transfer in Manufacturing
Artificial intelligence (AI) can help companies in the process industry capture, retain and access valuable historical expertise and ease the transition for new colleagues in the plant.
19.03.2024 • News
2024 Guidance Suspended: API Production Paused in Brindisi, Italy
EuroAPI today announces that its Italian subsidiary, EuroAPI Italy S.R.L., is suspending the production of all APIs (active pharmaceutical ingredients) in Brindisi.
Generative AI in Chromatographic Analysis
Generative AI can impact the field of chromatography in various innovative ways. However, great care needs to be taken to validate any use of this emerging technology from a technical, quality and regulatory perspective.
19.03.2024 • News
Roquette Strategically Acquires IFF Pharma Solutions
Roquette, a plant-based ingredients and pharmaceutical excipients manufacturer, announced today an agreement to acquire IFF Pharma Solutions, an excipients for oral dosage solutions producer, to reinforce its position as a major partner to the pharmaceutical industry.
• 19.03.2024 • News • Innovation
Noncanonical Amino Acids Made by Enzymes
Aralez Bio, a San Francisco-based start-up, has engineered a platform of enzymes that creates 100 times more compound diversity using processes that are also 50 times greener than conventional methods.
High Dynamics in the Supply Chain
Interview with Markus Mau, President of the ELA, about developments for the logistics sector.
Revolutionizing Green Chemical Production with Ultrasound
Biorefining allows low-carbon feedstocks – such as lignocellulosic biomass – to be processed into intermediate chemicals that can be made into renewable plastics for the automotive industry. Sonichem has developed a breakthrough biorefinery technique that uses ultrasonic energy alongside mild organic acids to fractionate softwood sawdust into hemicellulose sugars, microcrystalline cellulose and high-quality lignin.
Digital Twin Meets General Cargo Logistics
The logistics industry urgently needs digital transformation to ensure quality and to tackle challenges such as the shortage of skilled workers and sustainability.
18.03.2024 • News
Ecorich Solutions – Turning waste into food
African start-up Ecorich Solutions uses an innovative technology called “the Wastebot decomposer machine” to convert organic waste into organic fertilizer. The process involves the breakdown of organic waste using soil based microbial enzymes under a temperature regulated mechanism.
18.03.2024 • News
Partex and Sanofi Partner for AI-Enhanced Dossier Improvement
Partex Group, an AI-driven drug discovery company, today announces a collaboration with global pharmaceutical company Sanofi, aimed at using Partex’s AI technology to enhance the value of Sanofi's out-licensing portfolio.
15.03.2024 • News
Chemlink Specialities and Addi-Tec Form Harke UK
Germany-headquartered chemical distributor Harke Group announced that its subsidiaries Chemlink Specialities and Addi-Tec have merged and rebranded as Harke UK, effective Feb.1, 2024.
